Welcome to our dedicated page for Nano Mobile Healthcare SEC filings (Ticker: VNTH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Nano Mobile Healthcare's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Nano Mobile Healthcare's regulatory disclosures and financial reporting.
Nano Mobile Healthcare, Inc. reported that on July 29, 2026 its control shareholder, Opportunity Zones Capital LLC, closed the sale of 50,000,000 shares of preferred stock (a control block) to Mr. Cheng Chung Sing under a Securities Purchase Agreement dated March 31, 2026.
The company also entered into a Share Exchange and Acquisition Agreement with Neptune Engineering Limited, under which Neptune is expected to become a 100% wholly owned operating subsidiary. Upon consummation, Nano Mobile Healthcare will acquire all 10,000 ordinary shares of Neptune and Neptune shareholders will receive 20,000,000 post restructuring common shares of Nano Mobile Healthcare. The agreement includes customary representations, warranties and covenants, including regulatory approval efforts and a Neptune shareholder vote. Following execution, the board elected Cheng Chung Sing as director and chairman, Cheng Chung Yu as director and CEO, and Angel Yik as director, secretary and CFO, while Roy Watson continues as president.